Professor Robert D. Rogers
Robert Rogers is Professor in Cognitive Neuroscience at the Department of Psychiatry, University of Oxford. Recently, he has begun to investigate the neural mechanisms of the cognitive biases that promote problem gambling behaviour.
Robert is Professor in Cognitive Neuroscience at the Department of Psychiatry (University of Oxford), working on a study of the characteristics of online gamblers in collaboration with the OII. The dominant theme of his research is the neural substrates of cognitive control, action selection and emotional decision-making in both health and psychological illness such as substance misuse and personality disorder. His work involves a mixture of cognitive psychology, psychopharmacology and brain imaging methodologies. Recently, he has begun to investigate the neural mechanisms of the cognitive biases that promote problem gambling behaviour.
Positions held at the OII
- Research Associate, January 2007 -
July 2006 - December 2007
Expanding our understanding of online gambling by undertaking a web-based survey of users of Internet gambling sites, covering areas such as demographic and occupational characteristics, psychological characteristics, and attitudes to risk.
- Campbell-Meiklejohn, D., Woolrich, M.W., Passingham, R.E. and Rogers, R.D. (2008) Knowing when to stop: the brain mechanisms of loss-chasing in gambling. Biological Psychiatry.
- Kirkpatrick, T., Joyce, E., Milton, J., Duggan, C., Tyrer, P. and Rogers, R.D. (2007) Altered emotional decision-making in prisoners with borderline personality disorder. Journal of Personality Disorder 21: 243-261.
- Wood, R.M., Rilling, J.K., Sanfey, A.G., Bhagwagar, Z. and Rogers, R.D. (2006) The effects of altering 5-HT activity on the performance of an iterated Prisoner's Dilemma (PD) game in healthy volunteers. Neuropsychopharmacology 31: 1075-1084.
- Morgan, M.J., Impallomeni, L.C., Pirona, A. and Rogers, R.D. (2006) Elevated impulsivity and impaired decision-making in abstinent ecstasy (MDMA) users compared to polydrug and drug-naive controls. Neuropsychopharmacology 31: 1562-1573.